Wikidata

(Q34575066)

English

Sergliflozin, a novel selective inhibitor of low-affinity sodium glucose cotransporter (SGLT2), validates the critical role of SGLT2 in renal glucose reabsorption and modulates plasma glucose level

scientific article

In more languages

Statements

title
Sergliflozin, a novel selective inhibitor of low-affinity sodium glucose cotransporter (SGLT2), validates the critical role of SGLT2 in renal glucose reabsorption and modulates plasma glucose level (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
17050778
retrieved
3 August 2017
main subject
glycobiology
0 references
glucose
0 references
author name string
Kenji Katsuno
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
17050778
retrieved
3 August 2017
Yoshikazu Fujimori
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
17050778
retrieved
3 August 2017
Yukiko Takemura
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
17050778
retrieved
3 August 2017
Masahiro Hiratochi
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
17050778
retrieved
3 August 2017
Fumiaki Itoh
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
17050778
retrieved
3 August 2017
Yoshimitsu Komatsu
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
17050778
retrieved
3 August 2017
Hideki Fujikura
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
17050778
retrieved
3 August 2017
Masayuki Isaji
series ordinal
8
1 reference
stated in
Europe PubMed Central
PubMed ID
17050778
retrieved
3 August 2017
publication date
18 October 2006
1 reference
stated in
Europe PubMed Central
PubMed ID
17050778
retrieved
3 August 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q34575066&oldid=1766839917"